• 1997

Company Description

Oxagen is a biopharmaceutical company developing small molecule drugs addressing asthma, and chronic allergic and inflammatory conditions.

Oxagen Limited, a biopharmaceutical company, provides drug discovery and development solutions. It offers molecule drugs for the treatment of asthma, autoimmune disease, inflammatory bowel, psoriasis, allergy, and rheumatoid arthritis diseases. Oxagen Limited was founded in 1997 and is based in Abingdon, the United Kingdom.